← Leaderboards
Theodoros Karantanos
Johns Hopkins University
$515,160
Attributed
$515,160
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $171.7K · FY2023–25$200K$150K$100K$50K$0
'23
'24
'25
Funding mix
By agency
NIH$515,160 · 1
By mechanism
K08$515,160 · 1
Top collaborators
No co-investigators on record.
Most similar at Johns Hopkins University
Same institution · by research overlap
- Steven D Gore$7,773,366
- Stephen B Baylin$40,109,757
- Gregory Joseph Riggins$11,126,953
- Richard J Jones$17,555,212
- Nancy E Davidson$32,860,580
Others in their field
Other Rising Stars on “Androgen Receptor”
- Remi Adelaiye-Ogala · State University Of New York At Buffalo$2,864,216
- Megan K Ruhland · Oregon Health & Science University$2,265,578
- Grinu Mathew · University Of Nebraska Medical Center$2,222,661
- Konrad Hermann Stopsack · Massachusetts General Hospital$2,049,685
- Rajesh Krishnan · Oncternal Therapeutics, Inc.$1,810,779
- Zhiguo Li · University Of Kentucky$1,749,738
Research focus
Androgen ReceptorAzacitidineBone MarrowBurden Of IllnessCareerCareer DevelopmentCcrl2 GeneCell CycleCell GrowthCellsCell SurfaceChemokine ReceptorComputational BiologyCrispr/Cas TechnologyCrispr ScreenC-TerminalCytoplasmDevelopment PlansDna RepairDrug ScreeningDysmyelopoietic SyndromesEarly EndosomeEndocytosisAbnormal Cell
Grant awards (3)
CCRL2 as a Regulator of Growth and Novel Target in Myelodysplastic Syndrome$171,720
K08 · FY2025 · HL · contact PI
CCRL2 as a Regulator of Growth and Novel Target in Myelodysplastic Syndrome$171,720
K08 · FY2024 · HL · contact PI
CCRL2 as a Regulator of Growth and Novel Target in Myelodysplastic Syndrome$171,720
K08 · FY2023 · HL · contact PI